1 most recent filing and news item mentioning IART. Updated every 60 seconds.
Earnings|GuidanceJul 29, 2026Neutral
Integra LifeSciences reported Q2 2026 revenues of $418.8 million and GAAP earnings per share of $0.06, reaffirming its 2026 organic revenue and adjusted EPS guidance.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.